I. V. Shirinsky

727 total citations
37 papers, 316 citations indexed

About

I. V. Shirinsky is a scholar working on Rheumatology, Pharmacology and Molecular Biology. According to data from OpenAlex, I. V. Shirinsky has authored 37 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Rheumatology, 14 papers in Pharmacology and 10 papers in Molecular Biology. Recurrent topics in I. V. Shirinsky's work include Osteoarthritis Treatment and Mechanisms (15 papers), Inflammatory mediators and NSAID effects (14 papers) and Rheumatoid Arthritis Research and Therapies (10 papers). I. V. Shirinsky is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (15 papers), Inflammatory mediators and NSAID effects (14 papers) and Rheumatoid Arthritis Research and Therapies (10 papers). I. V. Shirinsky collaborates with scholars based in Russia, United States and Australia. I. V. Shirinsky's co-authors include V. S. Shirinsky, Uxía Nogueira-Recalde, Francisco J. Blanco, Paul D. Robbins, Eduardo Domínguez, Marı́a Isabel Loza, Martin Lotz, B. Caramés, Diego Grassi and Kozlov Va and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Arthritis Research & Therapy.

In The Last Decade

I. V. Shirinsky

28 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. V. Shirinsky Russia 9 156 106 65 54 53 37 316
V. S. Shirinsky Russia 9 128 0.8× 103 1.0× 60 0.9× 43 0.8× 43 0.8× 34 282
Sandra Pérez-Baos Spain 10 155 1.0× 132 1.2× 78 1.2× 57 1.1× 67 1.3× 15 374
Erika Barboza Prado Lopes United States 9 195 1.3× 104 1.0× 60 0.9× 41 0.8× 71 1.3× 13 309
Waka Yokoyama Japan 9 140 0.9× 117 1.1× 42 0.6× 78 1.4× 76 1.4× 12 398
Dong‐Hyeon Suh South Korea 9 70 0.4× 128 1.2× 92 1.4× 114 2.1× 18 0.3× 9 384
Chien-Hsing Lee Taiwan 6 45 0.3× 144 1.4× 33 0.5× 71 1.3× 40 0.8× 10 281
Yütong Miao China 7 101 0.6× 109 1.0× 48 0.7× 96 1.8× 7 0.1× 9 331
Jessica Smith United Kingdom 10 52 0.3× 150 1.4× 79 1.2× 52 1.0× 17 0.3× 17 341
Ingrid Yao Mattisson Sweden 12 58 0.4× 126 1.2× 43 0.7× 135 2.5× 13 0.2× 18 370
Olga Bloch Israel 13 52 0.3× 82 0.8× 34 0.5× 107 2.0× 19 0.4× 24 331

Countries citing papers authored by I. V. Shirinsky

Since Specialization
Citations

This map shows the geographic impact of I. V. Shirinsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. V. Shirinsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. V. Shirinsky more than expected).

Fields of papers citing papers by I. V. Shirinsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. V. Shirinsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. V. Shirinsky. The network helps show where I. V. Shirinsky may publish in the future.

Co-authorship network of co-authors of I. V. Shirinsky

This figure shows the co-authorship network connecting the top 25 collaborators of I. V. Shirinsky. A scholar is included among the top collaborators of I. V. Shirinsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. V. Shirinsky. I. V. Shirinsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shirinsky, I. V., et al.. (2023). Efficacy and safety of curcumin in patients with metabolic phenotype of osteoarthritis: A pilot study. SHILAP Revista de lepidopterología. 25(5). 1099–1102.
2.
Shirinsky, I. V., et al.. (2023). Comparative analysis of the expression of the soluble IL-7 receptor in patients with arthropathy. SHILAP Revista de lepidopterología. 25(5). 1091–1098.
3.
4.
Neogi, Tuhina, David J. Hunter, Melvin Churchill, et al.. (2022). Observed efficacy and clinically important improvements in participants with osteoarthritis treated with subcutaneous tanezumab: results from a 56-week randomized NSAID-controlled study. Arthritis Research & Therapy. 24(1). 78–78. 17 indexed citations
5.
Shirinsky, V. S. & I. V. Shirinsky. (2022). Osteoimmunology: an interdisciplinary approach to studying the relationships between immune and bone cells. SHILAP Revista de lepidopterología. 24(5). 911–930. 1 indexed citations
6.
7.
Shirinsky, I. V., et al.. (2020). Tear cytokines as potential biomarkers in non-infectious uveitis: post hoc analysis of a randomised clinical trial. Graefe s Archive for Clinical and Experimental Ophthalmology. 258(8). 1813–1819. 3 indexed citations
8.
Nogueira-Recalde, Uxía, Francisco J. Blanco, Marı́a Isabel Loza, et al.. (2019). Fibrates as drugs with senolytic and autophagic activity for osteoarthritis therapy. EBioMedicine. 45. 588–605. 112 indexed citations
9.
Shirinsky, I. V. & V. S. Shirinsky. (2018). H1-antihistamines are associated with lower prevalence of radiographic knee osteoarthritis: a cross-sectional analysis of the Osteoarthritis Initiative data. Arthritis Research & Therapy. 20(1). 116–116. 20 indexed citations
10.
Shirinsky, I. V. & V. S. Shirinsky. (2017). Effects of medication-treated diabetes on incidence and progression of knee osteoarthritis: a longitudinal analysis of the Osteoarthritis Initiative data. Rheumatology International. 37(6). 983–991. 18 indexed citations
11.
Shirinsky, V. S., et al.. (2017). CLINICAL EFFICIENCY AND SAFETY OF FENOFIBRATE, A PPARα AGONIST, IN THE PATIENTS WITH DIABETESASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY. Medical Immunology (Russia). 19(2). 165–174. 1 indexed citations
12.
Shirinsky, V. S., et al.. (2016). DIABETES-ASSOCIATED OSTEOARTHRITIS: A SYNTROPY?. Medical Immunology (Russia). 18(4). 317–330. 4 indexed citations
13.
Schneider, Maren, V. S. Shirinsky, & I. V. Shirinsky. (2016). CULTURES OF FIBROBLAST-LIKE SYNOVIAL CELLS FROM PATIENTS WITH RHEUMATOID ARTHRITIS: PROPERTIES AND OPPORTUNITIES. Medical Immunology (Russia). 18(2). 107–118.
14.
Shirinsky, I. V., et al.. (2015). FRI0201 Efficacyand Safety of Simvastatinin Uveitis Associated with HLAB27 and/or Rheumatic Diseases: A Randomized, Open-Label Study. Annals of the Rheumatic Diseases. 74. 497–497. 1 indexed citations
15.
Shirinsky, I. V., et al.. (2014). EFFECT OF SIMVASTATIN THERAPY UPON IMMUNOLOGICAL MARKERS OF ATHEROSCLEROSIS IN THE PATIENTS WITH RHEUMATOID ARTHRITIS. Medical Immunology (Russia). 13(1). 101–101. 1 indexed citations
16.
Shirinsky, I. V. & V. S. Shirinsky. (2014). EFFECTS OF STATINS UPON ANTIGEN-SPECIFIC LYMPHOCYTE ACTIVATION IN PATIENTS WITH RHEUMATOID ARTHRITIS: AN IN VITRO STUDY. Medical Immunology (Russia). 10(1). 77–77.
17.
Shirinsky, I. V., et al.. (2014). EFFICACY AND SAFETY OF SIMVASTATIN IN RHEUMATOID ARTHRITIS: AN OPEN-LABEL, CONTROLLED STUDY. Medical Immunology (Russia). 10(4-5). 477–477.
18.
Shirinsky, I. V. & V. S. Shirinsky. (2013). Treatment of erosive osteoarthritis with peroxisome proliferator-activated receptor alpha agonist fenofibrate: a pilot study. Rheumatology International. 34(5). 613–616. 20 indexed citations
19.
Shirinsky, I. V., et al.. (2012). The effects of fenofibrate on inflammation and cardiovascular markers in patients with active rheumatoid arthritis: a pilot study. Rheumatology International. 33(12). 3045–3048. 25 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by V. S. Shirinsky Breakdown of academic impact, for papers by Sandra Pérez-Baos Breakdown of academic impact, for papers by Erika Barboza Prado Lopes Breakdown of academic impact, for papers by Waka Yokoyama Breakdown of academic impact, for papers by Dong‐Hyeon Suh Breakdown of academic impact, for papers by Chien-Hsing Lee Breakdown of academic impact, for papers by Yütong Miao Breakdown of academic impact, for papers by Jessica Smith Breakdown of academic impact, for papers by Ingrid Yao Mattisson Breakdown of academic impact, for papers by Olga Bloch
Rankless by CCL
2026